BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30176535)

  • 1. CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates.
    Dumontet C; Peyrottes S; Rabeson C; Cros-Perrial E; Géant PY; Chaloin L; Jordheim LP
    Eur J Med Chem; 2018 Sep; 157():1051-1055. PubMed ID: 30176535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors.
    Iqbal J; Saeed A; Raza R; Matin A; Hameed A; Furtmann N; Lecka J; Sévigny J; Bajorath J
    Eur J Med Chem; 2013; 70():685-91. PubMed ID: 24215819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of Substituted 5'-Aminoadenosine Derivatives and Evaluation of Their Inhibitory Potential toward CD73.
    Ghoteimi R; Nguyen VT; Rahimova R; Grosjean F; Cros-Perrial E; Uttaro JP; Mathé C; Chaloin L; Jordheim LP; Peyrottes S
    ChemMedChem; 2019 Aug; 14(15):1431-1443. PubMed ID: 31264794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of β-hydroxyphosphonate nucleoside analogues as cytosolic 5'-nucleotidase II potential inhibitors: synthesis, in vitro evaluation and molecular modeling studies.
    Meurillon M; Marton Z; Hospital A; Jordheim LP; Béjaud J; Lionne C; Dumontet C; Périgaud C; Chaloin L; Peyrottes S
    Eur J Med Chem; 2014 Apr; 77():18-37. PubMed ID: 24607586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation.
    Bavaresco L; Bernardi A; Braganhol E; Cappellari AR; Rockenbach L; Farias PF; Wink MR; Delgado-Cañedo A; Battastini AM
    Mol Cell Biochem; 2008 Dec; 319(1-2):61-8. PubMed ID: 18636315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors.
    Junker A; Renn C; Dobelmann C; Namasivayam V; Jain S; Losenkova K; Irjala H; Duca S; Balasubramanian R; Chakraborty S; Börgel F; Zimmermann H; Yegutkin GG; Müller CE; Jacobson KA
    J Med Chem; 2019 Apr; 62(7):3677-3695. PubMed ID: 30895781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor.
    Wang Y; Wang C; Zhu Y; Zhang Y; Chen B; Wu Y; Yao J; Miao Z
    Bioorg Med Chem Lett; 2021 Feb; 34():127758. PubMed ID: 33359608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Substituted-1,2,3-triazolo nucleotide analogues as CD73 inhibitors, their synthesis, in vitro screening, kinetic and in silico studies.
    Ghoteimi R; Braka A; Rodriguez C; Cros-Perrial E; Tai Nguyen V; Uttaro JP; Mathé C; Chaloin L; Ménétrier-Caux C; Jordheim LP; Peyrottes S
    Bioorg Chem; 2021 Feb; 107():104577. PubMed ID: 33450542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes.
    Bhattarai S; Pippel J; Scaletti E; Idris R; Freundlieb M; Rolshoven G; Renn C; Lee SY; Abdelrahman A; Zimmermann H; El-Tayeb A; Müller CE; Sträter N
    J Med Chem; 2020 Mar; 63(6):2941-2957. PubMed ID: 32045236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel Non-Nucleoside Inhibitors Interacting with Dizinc Ions of CD73.
    Shi C; Chang L; Wang J; Dai J; Xu W; Tang J; Mei W; Zhang C; Wang Z; Liao Y; Zhang X; Jiang W; Zhang G; Zhao Z; Xu Y; Zhu L; Li H
    J Med Chem; 2024 Jun; 67(11):9686-9708. PubMed ID: 38809692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.
    Baqi Y; Lee SY; Iqbal J; Ripphausen P; Lehr A; Scheiff AB; Zimmermann H; Bajorath J; Müller CE
    J Med Chem; 2010 Mar; 53(5):2076-86. PubMed ID: 20146483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-Methylguanosine monophosphate analogues with 5'-(1,2,3-triazoyl) moiety: Synthesis and evaluation as the inhibitors of cNIIIB nucleotidase.
    Kozarski M; Kubacka D; Wojtczak BA; Kasprzyk R; Baranowski MR; Kowalska J
    Bioorg Med Chem; 2018 Jan; 26(1):191-199. PubMed ID: 29195795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production.
    Du X; Moore J; Blank BR; Eksterowicz J; Sutimantanapi D; Yuen N; Metzger T; Chan B; Huang T; Chen X; Chen Y; Duong F; Kong W; Chang JH; Sun J; Zavorotinskaya T; Ye Q; Junttila MR; Ndubaku C; Friedman LS; Fantin VR; Sun D
    J Med Chem; 2020 Sep; 63(18):10433-10459. PubMed ID: 32865411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 Inhibitors.
    Scortichini M; Idris RM; Moschütz S; Keim A; Salmaso V; Dobelmann C; Oliva P; Losenkova K; Irjala H; Vaittinen S; Sandholm J; Yegutkin GG; Sträter N; Junker A; Müller CE; Jacobson KA
    J Med Chem; 2022 Feb; 65(3):2409-2433. PubMed ID: 35080883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the extracellular catabolism of nucleotides are involved in the antiproliferative effect of quercetin in human bladder cancer T24 cells.
    Rockenbach L; Bavaresco L; Fernandes Farias P; Cappellari AR; Barrios CH; Bueno Morrone F; Oliveira Battastini AM
    Urol Oncol; 2013 Oct; 31(7):1204-11. PubMed ID: 22137869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ecto-5'-nucleotidase on human breast cancer cell growth in vitro and in vivo.
    Zhou X; Zhi X; Zhou P; Chen S; Zhao F; Shao Z; Ou Z; Yin L
    Oncol Rep; 2007 Jun; 17(6):1341-6. PubMed ID: 17487388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lead optimization and biological evaluation of fragment-based cN-II inhibitors.
    Guillon R; Rahimova R; Preeti ; Egron D; Rouanet S; Dumontet C; Aghajari N; Jordheim LP; Chaloin L; Peyrottes S
    Eur J Med Chem; 2019 Apr; 168():28-44. PubMed ID: 30798051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The volatile anesthetic isoflurane increases endothelial adenosine generation via microparticle ecto-5'-nucleotidase (CD73) release.
    Kim M; Ham A; Kim KY; Brown KM; Lee HT
    PLoS One; 2014; 9(6):e99950. PubMed ID: 24945528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide and nucleoside analogues as inhibitors of cytosolic 5'-nucleotidase I from heart.
    Garvey EP; Lowen GT; Almond MR
    Biochemistry; 1998 Jun; 37(25):9043-51. PubMed ID: 9636049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5'-Nucleotidase (CD73) Inhibitors.
    Bhattarai S; Freundlieb M; Pippel J; Meyer A; Abdelrahman A; Fiene A; Lee SY; Zimmermann H; Yegutkin GG; Sträter N; El-Tayeb A; Müller CE
    J Med Chem; 2015 Aug; 58(15):6248-63. PubMed ID: 26147331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.